What sectors does Paradigm Capital focus on?

Paradigm Capital focuses on Biotech, Crypto & Web3, Energy, Healthtech.

Where is Paradigm Capital located?

Paradigm Capital is headquartered in Toronto, CA.

Paradigm Capital

Institutional investor

Toronto · 8 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Paradigm Capital

307 people in our graph share verified history with the Paradigm Capital team — schools, employers, funds. One of them is your warm intro.

Andrew Miklasunlockedknows Scott McAuley · together at University of Toronto (overlapped)

×4knows the team · via McGill University

×7knows the team · via University of Toronto

✨ Fox Verdict

Investment thesis

Paradigm Capital is an employee-owned independent Canadian investment dealer focused on companies with strong long-term secular growth. It provides investment banking, research, and sales & trading services connecting institutional investors with growing companies.

Invests inBiotech Crypto & Web3 Energy Healthtech Canada Grand Cayman Toronto

Source: firm website, verified Sep 1, 2026.

Toronto, CA

Founded

1999

Last 12 months

1 investment

AUM

$2.4B

Tracked investments

Team · 8 people

from the firm's website

David Roland· Chief Executive Officer

Founding Partner of Paradigm in 1999 with a career spanning institutional sales, research and investment banking. Previously worked at Gordon Capital Corp. and is a McGill University graduate.

John Bellamy· Managing Director, Institutional Equity Sales

Founding Partner of Paradigm in 1999 with over 20 years in the investment industry, previously at Sprott Securities and Nesbitt Burns. Managing Director of Institutional Sales since 2003 and a board member of The Yellow Bus Foundation.

Casey Walsh· Chief Financial Officer

CFO with over 20 years of buy-side, sell-side and operating experience. Previously CFO of a PE-owned industrial minerals company and held roles at Arena Advisors, Merrill Lynch and Newcourt Credit Group; holds an MBA from Kellogg and is a CFA and CPA, CA.

Ian Joseph· President

President with 25 years of experience as an analyst and portfolio manager. Former VP of equity investments at Altamira and TAL Group Asset Management and named equity fund manager of the year in 2000.

Michael Roland· Chief Operating Officer and General Counsel· Toronto, Ontario, Canadain

COO and General Counsel who joined Paradigm in 2009. Previously VP, Legal at CI Financial and a corporate/commercial and environmental litigator at Fraser Milner Casgrain (now Dentons); holds an LL.B. from Dalhousie and a BA from McGill.

Naomi Ebata· Institutional Equity Sales

CFA charterholder with over 25 years of investment industry experience who joined Paradigm in 2009 after 20 years at CIBC World Markets, where she was a Managing Director in institutional equity sales.

Peter Dey· Chairman

Chairman of Paradigm and a veteran corporate director; former Partner at Osler, Hoskin & Harcourt LLP and former Chairman of the Ontario Securities Commission and Morgan Stanley Canada. Author of the 'Dey report' on corporate governance.

Scott McAuley· Head of Research· Canadain

Head of Research who joined Paradigm in 2019 as an equity research analyst in healthcare and biotechnology. Previously spent 10 years in academic research and with University of Toronto spin-offs; holds a PhD and MSc from U of T and a BSc from McGill.

What they invest in

from 2 of 2 portfolio companies

Biotech ×1Deep Tech ×1Energy ×1Healthtech ×1

HQs:United States×2

Investments · 2 tracked

founders shown can be your intro path

By year:2026 · 1 2022 · 12 dated

Antares NuclearJul 2026

Nuclear fission startup building transportable microreactors for U.S. defense and space customers.

EnergyRedondo Beach, US

Julia DeWahl(Executive Officer, Director, Promoter)inJordan Bramble(Executive Officer, Director, Promoter)in

BoardJack Altman(Director)Alexander Hartz(Director)inAlana Palmedo(Director)in

Co-investorsCaffeinated Capital Industrious Ventures Paradigm Point72 Ventures Shine Capital

Praxispraxismedicines.com in 𝕏Mar 2022 · $15M

Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy.

BiotechDeep TechHealthtechBoston, US

Steve Petrou(Co-Founder, President of Research & Development)inMarcio Souza(President & Chief Executive Officer)in

Co-investorsAvoro Capital Advisors Capria Ventures OCV Partners Alameda Research APOLLO PROJECTS Norwest Venture Partners +2 more

Portfolio news

latest coverage across their companies

Antares Nuclear has raised $470 Million in new Series C funding - intelligence360

Antares Nuclear · intelligence360.news · Aug 18, 2026

Frequently asked questions

What sectors does Paradigm Capital focus on?: Paradigm Capital focuses on Biotech, Crypto & Web3, Energy, Healthtech.
Where is Paradigm Capital located?: Paradigm Capital is headquartered in Toronto, CA.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Khosla Ventures

Khosla Ventures is a venture capital firm founded by Vinod Khosla.

$5K – $50M

OMERS Ventures

OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.

$5M – $25M

Version One Ventures

Version One Ventures is an early-stage venture firm that backs mission-driven founders building technology companies with generational potential, often committing from day one before a category is clear.

$250K – $500K

SV Angel

SV Angel is a firm that has backed startup founders since the 1990s, leveraging a large network of founders, industry leaders, and regulators to support portfolio companies.